Ixabepilone in Treating Patients With Locally Advanced or Metastatic Breast Cancer
This study has been completed.
Information provided by:
National Cancer Institute (NCI)
First received: September 6, 2002
Last updated: June 18, 2013
Last verified: January 2007
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||July 2007|
|Estimated Primary Completion Date:||No date given|
Denduluri N, Low JA, Lee JJ, Berman AW, Walshe JM, Vatas U, Chow CK, Steinberg SM, Yang SX, Swain SM. Phase II trial of ixabepilone, an epothilone B analog, in patients with metastatic breast cancer previously untreated with taxanes. J Clin Oncol. 2007 Aug 10;25(23):3421-7. Epub 2007 Jul 2.
Low J, Croarkin E, Parks R, et al.: Assessment of neurotoxicity in patients receiving BMS-247550 for metastatic breast cancer. [Abstract] Breast Cancer Research and Treatment 85.2: A-358, 2004. Also available online. Last accessed April 22, 2004.